The release of the American coronavirus vaccine brought down the shares of gaming companies

After Pfizer announced the successful testing of a coronavirus vaccine, shares of gaming companies went down massively. The “lucky ones” included Take-Two, Unity, Ubisoft, CD Projekt and many others.

Ico Partners analyst Thomas Bidaux wrote about this on Twitter last night. In his message, Bido did not directly name the manufacturer of the effective vaccine against COVID-19, but it was the American Pfizer that reported major successes. According to the pharmaceutical company, its drug reduces the risk of disease by 90%.

Against the background of the announcement of the vaccine, gaming companies that received windfall profits during the pandemic began to become sharply cheaper.

The drug’s release hit Unity the hardest. The shares of the engine developer have fallen by almost 14% in a day. This is despite the fact that the company only entered the stock market at the end of September and its securities were highly quoted — $68 on the day of placement and $119 at the peak.

A slightly less painful drop in the value of the shares turned out to be at Take-Two. The publisher lost 8.68%.

French Ubisoft also seriously felt the change in investor sentiment. Its shares have fallen by more than 5%.

Successful testing of the vaccine has affected other gaming companies as well. At the time of writing, Electronic Arts fell by 1.8%, CD Projekt — by 3.05%, and Activision Blizzard — by 4.31%.

Also on the topic:

• Unity’s valuation reached $18.1 billion after the IPO — twice as much as expectedThe main thing from the Take-Two report: revenue of $841 million, growth in digital sales and revenue from microtransactions
• Ubisoft earned €754 million in six months — 94% of revenue came from games from the back catalog
• Is there any news?